IRIS PubliCatt

Sette, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.288
EU - Europa 785
AS - Asia 243
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.285
PL - Polonia 423
CN - Cina 138
SE - Svezia 129
IE - Irlanda 47
IT - Italia 45
DE - Germania 41
SG - Singapore 33
VN - Vietnam 31
AT - Austria 25
GB - Regno Unito 22
RU - Federazione Russa 21
TR - Turchia 16
FR - Francia 12
IN - India 11
HK - Hong Kong 9
UA - Ucraina 9
FI - Finlandia 5
IR - Iran 5
BE - Belgio 2
EU - Europa 2
NO - Norvegia 2
PA - Panama 2
CA - Canada 1
GR - Grecia 1
RO - Romania 1
Totale 2.318
Salva come PNG Salva come JPEG
Città #
Warsaw 420
Fairfield 205
Chandler 134
Seattle 105
Woodbridge 97
Houston 94
Wilmington 90
Ashburn 89
Cambridge 68
Dublin 47
Nanjing 42
Redmond 41
Dearborn 32
Dong Ket 31
Jacksonville 27
Bremen 26
Princeton 26
Vienna 25
San Mateo 20
Boston 19
Singapore 19
Ann Arbor 18
Nanchang 18
Rome 18
Izmir 16
San Diego 15
Moscow 13
Guangzhou 10
Hong Kong 9
Redwood City 9
Andover 8
London 8
Augusta 7
Shenyang 7
Hangzhou 6
Norwalk 6
Chiswick 5
Hebei 5
Helsinki 5
Kish 5
Phoenix 5
Tianjin 5
Cattolica 4
Falls Church 4
Jiaxing 4
Mountain View 4
Acton 3
Beijing 3
Lanzhou 3
Marseille 3
Radoslaw 3
Brussels 2
Chicago 2
Edinburgh 2
Fremont 2
Genova 2
Gualdo Cattaneo 2
Jinan 2
Kunming 2
Milan 2
New York 2
Paris 2
Turin 2
Athens 1
Atlanta 1
Bergamo 1
Boardman 1
Bucharest 1
Caserta 1
Changsha 1
Colleferro 1
Fuzhou 1
Genoa 1
Huddinge 1
Islington 1
Los Angeles 1
Marcianise 1
Miami 1
Nagold 1
Ningbo 1
Oslo 1
Ottawa 1
Padova 1
Panama City 1
Price 1
Ruvo Di Puglia 1
Sandston 1
Santa Clara 1
Shanghai 1
Shenzhen 1
Washington 1
Wuhan 1
Totale 1.939
Salva come PNG Salva come JPEG
Nome #
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 273
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 253
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 251
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells 249
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 243
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 231
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 73
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 67
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 60
Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma 54
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts 54
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 51
THERAPEUTIC TARGETING OF RAF-INDUCED PARADOXICAL ERK ACTIVATION WITH A VERTICAL COMBINATION HITTING MULTIPLE STEPS ALONG THE MAPK CASCADE 46
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells 45
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer 44
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts 42
SYNERGISTIC GROWTH INHIBITORY ACTIVITY OF COMBINED MEK/MTOR PATHWAY BLOCKADE IN PTEN-NULL CANCERS 41
Aloe-emodin exerts a potent anticancer and immunomodulatory activity on BRAF-mutated human melanoma cells 39
Chemotherapy resistance of glioblastoma stem cells [2] 37
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells 37
Identification and expansion of the tumorigenic lung cancer stem cell population 35
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells 30
The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms 29
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors 29
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction 27
CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells 21
Totale 2.361
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.937
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020756 0 0 102 226 40 53 87 83 55 20 67 23
2020/2021309 26 29 33 13 47 18 46 5 22 16 20 34
2021/2022233 36 29 4 10 12 14 8 44 11 11 33 21
2022/2023387 46 59 34 57 23 56 6 29 58 4 10 5
2023/2024170 8 69 4 6 2 9 9 1 3 1 37 21
2024/202521 19 2 0 0 0 0 0 0 0 0 0 0
Totale 2.361